- Home
- CODI vs DNTH Comparison
CODI vs DNTH Comparison
Compare CODI & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODI
- DNTH
- Stock Information
- Founded
- CODI 2005
- DNTH 2015
- Country
- CODI United States
- DNTH United States
- Employees
- CODI N/A
- DNTH N/A
- Industry
- CODI Home Furnishings
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- CODI Consumer Discretionary
- DNTH Health Care
- Exchange
- CODI Nasdaq
- DNTH Nasdaq
- Market Cap
- CODI 480.0M
- DNTH 568.6M
- IPO Year
- CODI 2006
- DNTH N/A
- Fundamental
- Price
- CODI $6.63
- DNTH $18.85
- Analyst Decision
- CODI Buy
- DNTH Strong Buy
- Analyst Count
- CODI 2
- DNTH 8
- Target Price
- CODI $26.00
- DNTH $53.00
- AVG Volume (30 Days)
- CODI 1.6M
- DNTH 315.6K
- Earning Date
- CODI 07-30-2025
- DNTH 08-07-2025
- Dividend Yield
- CODI 15.11%
- DNTH N/A
- EPS Growth
- CODI N/A
- DNTH N/A
- EPS
- CODI N/A
- DNTH N/A
- Revenue
- CODI $2,198,233,000.00
- DNTH $6,524,000.00
- Revenue This Year
- CODI $8.09
- DNTH N/A
- Revenue Next Year
- CODI $7.62
- DNTH N/A
- P/E Ratio
- CODI N/A
- DNTH N/A
- Revenue Growth
- CODI 11.87
- DNTH 102.36
- 52 Week Low
- CODI $6.00
- DNTH $13.37
- 52 Week High
- CODI $24.59
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- CODI 40.43
- DNTH 54.07
- Support Level
- CODI $6.14
- DNTH $17.27
- Resistance Level
- CODI $6.62
- DNTH $19.46
- Average True Range (ATR)
- CODI 0.28
- DNTH 1.07
- MACD
- CODI 0.26
- DNTH 0.15
- Stochastic Oscillator
- CODI 89.86
- DNTH 76.74
About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.